Rethinking pediatric clinical trials: guidelines from pediatric experts
2 April 2024
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
RESOURCES
Go Back
Read More »
Read More »
Read More »
Read More »
Read More »
Read More »
How Kayentis reduces the CO2 emissions of your eCOA projects with its carbon neutral program
In 2020, we implemented a carbon neutral program for all our clinical trials.
Our goal? To reduce project CO2 emissions without impacting cost, quality or timelines.
Learn more:
Overcoming challenges in long-lasting pediatric clinical trials – Insights from site experts
26 March 2024
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Tackling the specificities of NASH/MASH clinical trials
26 March 2024
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating
Mastering pediatric asthma clinical trials
19 March 2024
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of
The importance of ePRO to support NASH/NAFLD unmet clinical research and medical needs
14 March 2024
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally
How DCTs Can Help Pediatric Clinical Research – Insights From Site Experts
12 March 2024
In this second episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Last update : 31 March 2022